This is a preview of subscription content, log in via an institution to check access.
Literature Cited
L. V. Koval'chuk, E. V. Sokolova, and L. V. Burtseva, Byull. Éksp. Biol. Med., No. 8, 972 (1976).
H. George and J. Vaughan, Proc. Soc. Exp. Biol. (N.Y.),111, 514 (1962).
V. I. Kaledin, Y. N. Kuronov, N. I. Matienko, et al., J. Natl. Cancer Inst.61, 1393 (1978).
I. Kamo and H. Friendman, Adv. Cancer Res.,25, 271 (1977).
J. A. Katz, J. Immunol.,121, 1405 (1978).
G. R. Klimpel and C. S. Henney, J. Immunol.,120, 563 (1978).
J. W. Kreider, G. L. Bartlett and D. M. Purnell, J. Natl. Cancer Inst.,56, 803 (1976).
G. Mathe, J. L. Amiel, L. Schwarzenberg, et al., Lancet,1, 697 (1969).
G. Mathe, L. Schwarzenberg, et al., Lancet,1, 143 (1976).
L. Milas, in: Progress in Immunology III. Proceedings of the 3rd International Congress of Immunology, Sydney (1977), p. 582.
J. W. Proctor, et al., Eur. J. Cancer,13, 115 (1977).
S. E. Salmon, Cancer Res.,37, 1245 (1977).
M. A. Wainberg and E. Israel, Infect. Immun.,22, 328 (1978).
J. E. Woods, J. Surg. Oncol.,9, 15 (1977).
J. Wybron and H. H. Fudenberg, in: Clinical Tumor Immunology, Oxford (1976), p. 31.
Rights and permissions
About this article
Cite this article
Gankovskaya, L.V., Pyl'nova, T.I., Sokolova, E.V. et al. Production of a factor inhibiting macrophage migration and growth of melanoma B16 under the influence of BCG. Bull Exp Biol Med 90, 1275–1277 (1980). https://doi.org/10.1007/BF00830412
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00830412